17 Recruiting Solid Tumor Clinical Trials in Arizona
Explore active solid tumor research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Solid Tumor Studies in Arizona
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
📍 Phoenix Children'S Hospital — Phoenix, Arizona
View Study & Checklist ➔A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
📍 HonorHealth Research — Scottsdale, Arizona
View Study & Checklist ➔A Study of NDI 1150-101 in Patients With Solid Tumors
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Study of PYX-106 in Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
📍 Banner University Medical Center Tucson Campus — Tucson, Arizona
View Study & Checklist ➔A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
📍 ACRC/Arizona Clinical Research Center, Inc — Tucson, Arizona
View Study & Checklist ➔Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
📍 I-Mab Site 1016 — Goodyear, Arizona
View Study & Checklist ➔Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A Study of PYX-201 in Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
📍 CBCC Global Research Site 001 — Scottsdale, Arizona
View Study & Checklist ➔Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors
📍 HonorHealth — Scottsdale, Arizona
View Study & Checklist ➔